Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |